288 related articles for article (PubMed ID: 19538101)
41. Progesterone and progestins: neuroprotection and myelin repair.
Schumacher M; Sitruk-Ware R; De Nicola AF
Curr Opin Pharmacol; 2008 Dec; 8(6):740-6. PubMed ID: 18929681
[TBL] [Abstract][Full Text] [Related]
42. Brain inflammation, neuropsychiatric disorders, and immunoendocrine effects of luteolin.
Theoharides TC; Conti P; Economu M
J Clin Psychopharmacol; 2014 Apr; 34(2):187-9. PubMed ID: 24525647
[No Abstract] [Full Text] [Related]
43. New strategy for alerting central nervous system toxicity: Integration of blood-brain barrier toxicity and permeability in neurotoxicity assessment.
Hallier-Vanuxeem D; Prieto P; Culot M; Diallo H; Landry C; Tähti H; Cecchelli R
Toxicol In Vitro; 2009 Apr; 23(3):447-53. PubMed ID: 19135142
[TBL] [Abstract][Full Text] [Related]
44. Hesperidin as a Neuroprotective Agent: A Review of Animal and Clinical Evidence.
Hajialyani M; Hosein Farzaei M; Echeverría J; Nabavi SM; Uriarte E; Sobarzo-Sánchez E
Molecules; 2019 Feb; 24(3):. PubMed ID: 30759833
[TBL] [Abstract][Full Text] [Related]
45. Davunetide: a review of safety and efficacy data with a focus on neurodegenerative diseases.
Morimoto BH; Fox AW; Stewart AJ; Gold M
Expert Rev Clin Pharmacol; 2013 Sep; 6(5):483-502. PubMed ID: 23971871
[TBL] [Abstract][Full Text] [Related]
46. In vitro evidence supporting the therapeutic role of nicotine against neurodegeneration.
Williams E; Linert W
In Vivo; 2004; 18(3):391-9. PubMed ID: 15341195
[TBL] [Abstract][Full Text] [Related]
47. Nanowired drug delivery of antioxidant compound H-290/51 enhances neuroprotection in hyperthermia-induced neurotoxicity.
Muresanu DF; Sharma A; Tian ZR; Smith MA; Sharma HS
CNS Neurol Disord Drug Targets; 2012 Feb; 11(1):50-64. PubMed ID: 22229325
[TBL] [Abstract][Full Text] [Related]
48. Exploring the potential of quercetin in Alzheimer's Disease: Pharmacodynamics, Pharmacokinetics, and Nanodelivery systems.
Kaur K; Kulkarni YA; Wairkar S
Brain Res; 2024 Jul; 1834():148905. PubMed ID: 38565372
[TBL] [Abstract][Full Text] [Related]
49. A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties.
Harwood M; Danielewska-Nikiel B; Borzelleca JF; Flamm GW; Williams GM; Lines TC
Food Chem Toxicol; 2007 Nov; 45(11):2179-205. PubMed ID: 17698276
[TBL] [Abstract][Full Text] [Related]
50. Neuroprotective effects of antioxidants in the management of neurodegenerative disorders: A literature review.
Panahi Y; Rajaee SM; Johnston TP; Sahebkar A
J Cell Biochem; 2019 Mar; 120(3):2742-2748. PubMed ID: 29219206
[TBL] [Abstract][Full Text] [Related]
51. Statins: mechanisms of neuroprotection.
van der Most PJ; Dolga AM; Nijholt IM; Luiten PG; Eisel UL
Prog Neurobiol; 2009 May; 88(1):64-75. PubMed ID: 19428962
[TBL] [Abstract][Full Text] [Related]
52. Impact of sex steroids on neuroinflammatory processes and experimental multiple sclerosis.
Kipp M; Beyer C
Front Neuroendocrinol; 2009 Jul; 30(2):188-200. PubMed ID: 19393685
[TBL] [Abstract][Full Text] [Related]
53. Quercetin.
Altern Med Rev; 1998 Apr; 3(2):140-3. PubMed ID: 9577251
[No Abstract] [Full Text] [Related]
54. Quercetin. Monograph.
Kelly GS
Altern Med Rev; 2011 Jun; 16(2):172-94. PubMed ID: 21649459
[No Abstract] [Full Text] [Related]
55. Dihydroquercetin: More than just an impurity?
Weidmann AE
Eur J Pharmacol; 2012 Jun; 684(1-3):19-26. PubMed ID: 22513183
[TBL] [Abstract][Full Text] [Related]
56. Enhanced skin delivery of quercetin by microemulsion.
Kitagawa S; Tanaka Y; Tanaka M; Endo K; Yoshii A
J Pharm Pharmacol; 2009 Jul; 61(7):855-60. PubMed ID: 19589226
[TBL] [Abstract][Full Text] [Related]
57. Exploring the therapeutic potential of quercetin: A focus on its sirtuin-mediated benefits.
Ungurianu A; Zanfirescu A; Margină D
Phytother Res; 2024 May; 38(5):2361-2387. PubMed ID: 38429891
[TBL] [Abstract][Full Text] [Related]
58. A Critical Analysis of Quercetin as the Attractive Target for the Treatment of Parkinson's Disease.
Acıkara OB; Karatoprak GŞ; Yücel Ç; Akkol EK; Sobarzo-Sánchez E; Khayatkashani M; Kamal MA; Kashani HRK
CNS Neurol Disord Drug Targets; 2022; 21(9):795-817. PubMed ID: 34872486
[TBL] [Abstract][Full Text] [Related]
59. Neuroprotective effects of furopyrazole derivative of benzylindazole analogs on C2 ceramide-induced apoptosis in cultured cortical neurons.
Lin YC; Chou LC; Chen SC; Kuo SC; Huang LJ; Gean PW
Bioorg Med Chem Lett; 2009 Jun; 19(12):3225-8. PubMed ID: 19435666
[TBL] [Abstract][Full Text] [Related]
60. Quercetin in Animal Models of Alzheimer's Disease: A Systematic Review of Preclinical Studies.
Zhang XW; Chen JY; Ouyang D; Lu JH
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31941000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
